Axerion Therapeutics
Axerion Therapeutics is a biotech company focused on developing innovative therapeutics for neurological diseases and injuries.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Axerion Therapeutics Information
Geographic Data
Address:
City: New Haven
State: Connecticut
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$400k
Raised Total:$1M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury. Axerion was established in New Haven to develop and commercialize intellectual property licensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2011 | Venture Round | 1 | $400k |
Connecticut Innovations Connecticut Innovations |
4/2010 | Seed Round | 1 | $750k |
Connecticut Innovations Connecticut Innovations |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
